World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
45514
World Ranking
9125
National Ranking
4705

Paul A. Gurbel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul A. Gurbel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 777 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul A. Gurbel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul A. Gurbel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paul A. Gurbel is affiliated with Inova Fairfax Hospital in the United States and has a substantial publication record in the field of medicine, with a strong focus on cardiology and cardiovascular medicine.

The scientist's research spans several subfields including:

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Internal Medicine
  • Infectious Diseases
  • Epidemiology

Major topics covered in Paul A. Gurbel's work include:

  • Antiplatelet Therapy and Cardiovascular Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • COVID-19 Clinical Research Studies
  • Lipoproteins and Cardiovascular Health

Frequent publication venues for Paul A. Gurbel's research are:

  • Journal of the American College of Cardiology
  • Circulation
  • Journal of Thrombosis and Thrombolysis
  • The American Journal of Cardiology
  • Thrombosis and Haemostasis

Some recent representative papers authored or co-authored by the researcher include:

  • The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease (2020), published in Thrombosis and Haemostasis
  • Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium (2022), published in Nature Reviews Cardiology
  • Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS (2020), published in European Heart Journal
  • Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis (2021), published in European Heart Journal
  • Comparative Efficacy and Safety of Oral P2Y 12 Inhibitors in Acute Coronary Syndrome (2020), published in Circulation

Paul A. Gurbel frequently collaborates with several co-authors, including:

  • Udaya S. Tantry
  • Kevin P. Bliden
  • Sahib Singh
  • Young-Hoon Jeong
  • Rahul Chaudhary

Best Publications

  • Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.

    Paul A. Gurbel;Kevin P. Bliden;Bonnie L. Hiatt;Christopher M. O’Connor

  • Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy

    Alan R. Shuldiner;Jeffrey R. O’Connell;Kevin P. Bliden;Amish Gandhi

  • Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease The ONSET/OFFSET Study

    Paul A. Gurbel;Kevin P. Bliden;Kathleen Butler;Udaya S. Tantry

  • Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

    Laurent Bonello;Udaya S. Tantry;Rossella Marcucci;Ruediger Blindt

  • Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

    Jessica L. Mega;Tabassome Simon;Jean Philippe Collet;Jeffrey L. Anderson

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study

    Gregg W. Stone;Bernhard Witzenbichler;Giora Weisz;Michael J. Rinaldi

  • Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

    Udaya S. Tantry;Laurent Bonello;Daniel Aradi;Matthew J. Price

  • Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study.

    Paul A. Gurbel;Kevin P. Bliden;Kirk Guyer;Peter W. Cho

  • Ticagrelor with or without Aspirin in High-Risk Patients after PCI

    Roxana Mehran;Usman Baber;Samin K Sharma;David J Cohen

  • Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel Resistance

    Wei C. Lau;Paul A. Gurbel;Paul B. Watkins;Charlene J. Neer

  • Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study.

    Paul A. Gurbel;Kevin P. Bliden;Waiel Samara;Jason A. Yoho

  • Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.

    Paul A. Gurbel;Kevin P. Bliden;Kathleen Butler;Mark J. Antonino

  • Platelet function monitoring in patients with coronary artery disease

    Paul A. Gurbel;Richard C. Becker;Kenneth G. Mann;Steven R. Steinhubl

  • Evaluation of Dose-Related Effects of Aspirin on Platelet Function Results From the Aspirin-Induced Platelet Effect (ASPECT) Study

    Paul A. Gurbel;Kevin P. Bliden;Joseph DiChiara;Justin Newcomer

  • Increased Risk in Patients With High Platelet Aggregation Receiving Chronic Clopidogrel Therapy Undergoing Percutaneous Coronary Intervention: Is the Current Antiplatelet Therapy Adequate?

    Kevin P. Bliden;Joseph DiChiara;Udaya S. Tantry;Ashwani K. Bassi

  • Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes

    Robert F. Storey;Steen Husted;Robert A. Harrington;Stanley Heptinstall

  • The Relation of Dosing to Clopidogrel Responsiveness and the Incidence of High Post-Treatment Platelet Aggregation in Patients Undergoing Coronary Stenting

    Paul A. Gurbel;Kevin P. Bliden;Kevin M. Hayes;Jason A. Yoho

  • Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.

    Eliano Pio Navarese;Michalina Kołodziejczak;Volker Schulze;Paul A. Gurbel

  • Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention

    Dirk Sibbing;Daniel Aradi;Dimitrios Alexopoulos;Jurrien ten Berg

Frequent Co-Authors

Udaya S. Tantry
Udaya S. Tantry Johns Hopkins University
Dominick J. Angiolillo
Dominick J. Angiolillo University of Florida
E. Magnus Ohman
E. Magnus Ohman Duke University
Dean J. Kereiakes
Dean J. Kereiakes The Christ Hospital Health Network
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Robert F. Storey
Robert F. Storey University of Sheffield
Alan R. Shuldiner
Alan R. Shuldiner University of Maryland, Baltimore
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Matthew T. Roe
Matthew T. Roe Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond studying Medicine in the USA, many students explore alternative healthcare degrees online. These pathways can provide greater flexibility and may shorten the time to begin a rewarding medical career.

Advanced nursing roles are in high demand. Consider the online dnp programs for those aiming for leadership or educational positions in nursing. For those seeking a less rigorous entry, there are also options among the easiest online dnp programs.

If you want to join the healthcare workforce sooner, fast lpn program options allow you to become a Licensed Practical Nurse quickly. Additionally, for those interested in mental health, the shortest pmhnp program lets you become a Psychiatric Mental Health Nurse Practitioner in less time.

These online degrees and fast-track programs help open doors to diverse careers in healthcare, offering alternative routes to those interested in patient care, leadership, or specialty practice areas.

Best Scientists Citing Paul A. Gurbel

Trending Scientists

Recently Published Articles